Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

Streamline Investigators, Stuart A. Taylor*, Sue Mallett, Simon Ball, Sandy Beare, Gauraang Bhatnagar, Angshu Bhowmik, Peter Boavida, John Bridgewater, Caroline S. Clarke, Marian Duggan, Steve Ellis, Robert Glynne-Jones, Vicky Goh, Ashley M. Groves, Ayshea Hameeduddin, Sam M. Janes, Edward W. Johnston, Dow Mu Koh, Sara LockAnne Miles, Stephen Morris, Alison Morton, Neal Navani, Alfred Oliver, Terry O'Shaughnessy, Anwar R. Padhani, David Prezzi, Shonit Punwani, Laura Quinn, Hameed Rafiee, Krystyna Reczko, Andrea G. Rockall, Peter Russell, Harbir S. Sidhu, Nicola Strickland, Kathryn Tarver, Jonathan Teague, Steve Halligan, Ruth Evans, Khawaja Shahabuddin, Revanth Jannapureddy, Tina Mills-Baldock, Kishor Barhate, Zoltan Nagy, Sherif Raouf, Nathalie Rich, Tuck Kay Loke, Sofia Gourtsoyianni, Christian Kelly-Morland, Abel Jalloh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)
81 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology